Thanks for checking, but I recall something specific about the mention of "January". The only reason I ask is, Leo said during the shareholder meeting that he can't really give us more information about the 750mg patients(paraphrasing) until after he meets with the FDA. We know the briefing book has been submitted, so the meeting is definitely soon. I'm hoping we get some "top line" info on the K trial soon...